XML 43 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense
   2022   2021 
Selling, general and administrative  $780,818   $1,550,841 
Research and development   166,394    242,358 
Total stock-based compensation expense  $947,212   $1,793,199 

 

Schedule of weighted-average assumptions used in the Black-Scholes option-pricing model
   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted-
Average
Remaining
Contractual
Term (years)
   Aggregate
Intrinsic
Value(1)
 
Outstanding at September 30, 2020   492,842   $6.13    8.8   $96,088 
Granted   703,117   $5.83    
    
 
Exercised   (1,538)  $6.60    
    
 
Forfeited/Cancelled   (71,861)  $6.85    
    
 
Outstanding at September 30, 2021   1,122,560   $5.89    8.8   $127,339 
Granted   152,690   $1.50    
    
 
Exercised   
   $
    
    
 
Forfeited/Cancelled   (35,335)  $4.14    
    
 
Outstanding at September 30, 2022   1,239,915   $5.40    8.0   $89,295 
Vested and expected to vest at September 30, 2022   1,239,915   $5.40    8.0   $89,295 
Vested and exercisable at September 30, 2022   783,494   $5.76    7.7   $56,542 

 

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of our common stock as of September 30, 2022 and 2021 of $1.69 and $3.95 per share, respectively. As of September 30, 2022 and 2021, 1,125,710 and 1,055,376 outstanding options, respectively, had no intrinsic value.

 

Schedule of weighted-average assumptions used in the Black-Scholes option-pricing model
   2022   2021 
Expected stock price volatility   53.5%   55.9%
Expected life of options (years)   5.6    6.0 
Expected dividend yield   0%   0%
Risk free interest rate   2.3%   0.6%

 

Schedule of restricted stock unit activity
   Number of 
   Shares 
Non-vested at September 30, 2020   26,698 
Granted   13,776 
Vested   (29,090)
Non-vested at September 30, 2021   11,384 
Granted   443,670 
Vested   (40,624)
Non-vested at September 30, 2022   414,430